Special section on drug metabolism and the microbiome the presystemic interplay between gut microbiota and orally administered calycosin-7-O-β-D-Glucoside

Drug Metabolism and Disposition

Volumn 43, Issue 10, 2015, Pages 1601-1611

  Ruan, Jian Qing ^a   Li, Shang ^a   Li, Ya Ping ^a   Wu, Wen Jin ^a   Lee, Simon Ming Yuen ^a   Yan, Ru ^a  

^a UNIVERSITY OF MACAU   (Macao)

Author keywords

[No Author keywords available]

Indexed keywords

AGLYCONE; ASTRAGALUS ROOT; CALYCOSIN; CALYCOSIN 3' O GLUCURONIDE; CALYCOSIN 7 O BETA DEXTRO GLUCOSIDE; DRUG METABOLITE; FLAVONOID; PROBIOTIC AGENT; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR; CALYCOSIN-7-O-BETA-D-GLUCOSIDE; GLUCOSIDE; ISOFLAVONE DERIVATIVE;

ARTICLE; BACTERIAL GROWTH; BIFIDOBACTERIUM; CONTROLLED STUDY; DRUG PENETRATION; GLUCURONIDATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INTESTINE FLORA; LACTOBACILLUS; MICROFLORA; ORGANISMAL INTERACTION; PRIORITY JOURNAL; UMBILICAL VEIN ENDOTHELIAL CELL; ZEBRA FISH; ANIMAL; CACO 2 CELL LINE; COLITIS; DRUG EFFECTS; LIVER MICROSOME; MALE; METABOLISM; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

ADMINISTRATION, ORAL; ANIMALS; CACO-2 CELLS; COLITIS; GASTROINTESTINAL MICROBIOME; GLUCOSIDES; HUMANS; ISOFLAVONES; MALE; MICROSOMES, LIVER; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84946195327     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.115.065094     Document Type: Article

References (43)

1. Arroo RRJ, Androutsopoulos V, Patel A, Surichan S, Wilsher N, and Potter GA (2008) Phytoestrogens as natural prodrugs in cancer prevention: a novel concept. Phytochem Rev 7: 431-443 DOI: 10.1007/s11101-008-9093-5.
2. Arroo RRJ, Androutsopoulos V, Beresford K, Ruparelia K, Surichan S, Wilsher N, and Potter GA (2009) Phytoestrogens as natural prodrugs in cancer prevention: dietary flavonoids. Phytochem Rev 8:375-386 DOI: 10.1007/s11101-009-9128-6.
3. Bartosch S, Fite A, Macfarlane GT, and McMurdo ME (2004) Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl Environ Microbiol 70:3575-3581.
4. Byun R, Nadkarni MA, Chhour KL, Martin FE, Jacques NA, and Hunter N (2004) Quantitative analysis of diverse Lactobacillus species present in advanced dental caries. J Clin Microbiol 42:3128-3136.
5. Chen L, Li Z, Tang Y, Cui X, Luo R, Guo S, Zheng Y, and Huang C (2011) Isolation, identification and antiviral activities of metabolites of calycosin-7-O-β-D-glucopyranoside. J Pharm Biomed Anal 56:382-389.
6. Chinese Pharmacopoeia Commission (2010) Astragali Radix, in Pharmacopoeia of the People's Republic of China, 11th ed, p 283, China Medical Science Press, Beijing.
7. Choi SI, Heo TR, Min BH, Cui JH, Choi BH, and Park SR (2007) Alleviation of osteoarthritis by calycosin-7-O-β-D-glucopyranoside (CG) isolated from Astragali radix (AR) in rabbit osteoarthritis (OA) model. Osteoarthritis Cartilage 15:1086-1092.
8. Dorjgochoo T, Gao YT, Chow WH, Shu XO, Yang G, Cai Q, Rothman N, Cai H, Li H, and Deng X, et al. (2012) Major metabolite of F2-isoprostane in urine may be a more sensitive biomarker of oxidative stress than isoprostane itself. Am J Clin Nutr 96:405-414.
9. Dueñas M, Muñoz-González I, Cueva C, Jiménez-Girón A, Sánchez-Patán F, Santos-Buelga C, Moreno-Arribas MV, and Bartolomé B (2015) A survey of modulation of gut microbiota by dietary polyphenols. BioMed Res Int 2015:850902.
10. Fan Y, Wu DZ, Gong YQ, Zhou JY, and Hu ZB (2003) Effects of calycosin on the impairment of barrier function induced by hypoxia in human umbilical vein endothelial cells. Eur J Pharmacol 481:33-40.
11. Foxx-Orenstein AE and Chey WD (2012) Manipulation of the gut microbiota as a novel treatment strategy for gastrointestinal disorders. Am J Gastroenterol Suppl 1:41-46 DOI: 10.1038/ajgsup.2012.8.
12. Furet P, Bold G, Hofmann F, Manley P, Meyer T, and Altmann KH (2003) Identification of a new chemical class of potent angiogenesis inhibitors based on conformational considerations and database searching. Bioorg Med Chem Lett 13:2967-2971.
13. Granica S, Czerwińska ME, Zyzynska-Granica B, and Kiss AK (2013) Antioxidant and antiinflammatory flavonol glucuronides from Polygonum aviculare L. Fitoterapia 91:180-188.
14. Ho L, Ferruzzi MG, Janle EM, Wang J, Gong B, Chen TY, Lobo J, Cooper B, Wu QL, and Talcott ST, et al. (2013) Identification of brain-targeted bioactive dietary quercetin-3-O-glucuronide as a novel intervention for Alzheimer's disease. FASEB J 27:769-781.
15. Hu G, Siu SO, Li S, Chu IK, Kwan YW, Chan SW, Leung GP, Yan R, and Lee SM (2012) Metabolism of calycosin, an isoflavone from Astragali Radix, in zebrafish larvae. Xenobiotica 42:294-303.
16. Huang Y, Hu N, Gao X, Yan Z, Li S, Jing W, and Yan R (2015) Alterations of testosterone metabolism in microsomes from rats with experimental colitis induced by dextran sulfate sodium. Chem Biol Interact 232:38-48.
17. Koga T and Meydani M (2001) Effect of plasma metabolites of (+)-catechin and quercetin on monocyte adhesion to human aortic endothelial cells. Am J Clin Nutr 73:941-948.
18. Li S, Lou S, Lei BU, Chan TF, Kwan YW, Chan SW, Leung GP, Tsui SK, and Lee SM (2011) Transcriptional profiling of angiogenesis activities of calycosin in zebrafish. Mol Biosyst 7:3112-3121.
19. -ΔΔC(T) method. Methods 25:402-408.
20. Lu MF, Xiao ZT, and Zhang HY (2013) Where do health benefits of flavonoids come from? Insights from flavonoid targets and their evolutionary history. Biochem Biophys Res Commun 434:701-704.
21. Lv YW, Hu W, Wang YL, Huang LF, He YB, and Xie XZ (2011) Identification and determination of flavonoids in astragali radix by high performance liquid chromatography coupled with DAD and ESI-MS detection. Molecules 16:2293-2303.
22. Macfarlane GT and Macfarlane S (1997) Human colonic microbiota: ecology, physiology and metabolic potential of intestinal bacteria. Scand J Gastroenterol Suppl 222:3-9.
23. Matkowski A, Wozniak D, Lamer-Zarawska E, Oszmianski J, and Leszczynska A (2003) Flavonoids and phenol carboxylic acids in the oriental medicinal plant Astragalus membranaceus acclimated in Poland. Z Naturforsch C 58:602-604.
24. Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, and Pettersson S (2012) Host-gut microbiota metabolic interactions. Science 336:1262-1267.
25. Romano B, Pagano E, Montanaro V, Fortunato AL, Milic N, and Borrelli F (2013) Novel insights into the pharmacology of flavonoids. Phytother Res 27:1588-1596.
26. Ruan JQ, Leong WI, Yan R, and Wang YT (2010) Characterization of metabolism and in vitro permeability study of notoginsenoside R1 from Radix Notoginseng. J Agric Food Chem 58: 5770-5776.
27. Ruan JQ and Yan R (2014) Regioselective glucuronidation of the isoflavone calycosin by human liver microsomes and recombinant human UDP-glucuronosyltransferases. Chem Biol Interact 220:231-240.
28. Scanlan PD, Shanahan F, O'Mahony C, and Marchesi JR (2006) Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease. J Clin Microbiol 44:3980-3988.
29. Schrickx JA and Fink-Gremmels J (2007) Danofloxacin-mesylate is a substrate for ATP-dependent efflux transporters. Br J Pharmacol 150:463-469.
30. Shen P, Liu MH, Ng TY, Chan YH, and Yong EL (2006) Differential effects of isoflavones, from Astragalus membranaceus and Pueraria thomsonii, on the activation of PPARa, PPARg, and adipocyte differentiation in vitro. J Nutr 136:899-905.
31. Tang JY, Li S, Li ZH, Zhang ZJ, Hu G, Cheang LC, Alex D, Hoi MP, Kwan YW, and Chan SW, et al. (2010) Calycosin promotes angiogenesis involving estrogen receptor and mitogen-activated protein kinase (MAPK) signaling pathway in zebrafish and HUVEC. PLoS One 5: e11822.
32. Terao J (1999) Dietary flavonoids as antioxidants in vivo: conjugated metabolites of (-)-epicatechin and quercetin participate in antioxidative defense in blood plasma. J Med Invest 46: 159-168.
33. Vissiennon C, Nieber K, Kelber O, and Butterweck V (2012) Route of administration determines the anxiolytic activity of the flavonols kaempferol, quercetin and myricetin-are they prodrugs? J Nutr Biochem 23:733-740.
34. Xu F, Zhang Y, Xiao S, Lu X, Yang D, Yang X, Li C, Shang M, Tu P, and Cai S (2006) Absorption and metabolism of Astragali Radix decoction: in silico, in vitro, and a case study in vivo. Drug Metab Dispos 34:913-924.
35. Xu W, Li L, Lu J, Luo Y, Shang Y, and Huang K (2011) Analysis of caecal microbiota in rats fed with genetically modified rice by real-time quantitative PCR. J Food Sci 76:M88-M93.
36. Yan R, Ko NL, Ma B, Tam YK, and Lin G (2012) Metabolic conversion from co-existing ingredient leading to significant systemic exposure of Z-butylidenephthalide, a minor ingredient in Chuanxiong Rhizoma in rats. Curr Drug Metab 13:524-534.
37. Yan Z, Lin G, Ye Y, Wang Y, and Yan R (2014) A generic multiple reaction monitoring based approach for plant flavonoids profiling using a triple quadrupole linear ion trap mass spectrometry. J Am Soc Mass Spectrom 25:955-965.
38. Yu D, Duan Y, Bao Y, Wei C, and An L (2005) Isoflavonoids from Astragalus mongholicus protect PC12 cells from toxicity induced by L-glutamate. J Ethnopharmacol 98:89-94.
39. Zhang W, Jiang S, Qian D, Shang EX, and Duan JA (2014) Analysis of interaction property of calycosin-7-O-β-D-glucoside with human gut microbiota. J Chromatogr B Analyt Technol Biomed Life Sci 963:16-23.
40. Zhang YZ, Xu F, Dong J, Liang J, Hashi Y, Shang MY, Yang DH, Wang X, and Cai SQ (2012) Profiling and identification of the metabolites of calycosin in rat hepatic 9000 × g supernatant incubation system and the metabolites of calycosin-7-O-β-D-glucoside in rat urine by HPLC-DAD-ESI-IT-TOF-MS(n) technique. J Pharm Biomed Anal 70:425-439.
41. Cohen I (2013), inventor, Bionovo, Inc., assignee. Methods of detecting and treatment of cancers using Scutellaria barbata extract. U.S. patent 08512961 B2. 2013 Aug 20.
42. Zhao P, Su G, Xiao X, Hao E, Zhu X, and Ren J (2008) Chinese medicinal herb Radix Astragali suppresses cardiac contractile dysfunction and inflammation in a rat model of autoimmune myocarditis. Toxicol Lett 182:29-35.
43. Zhu Q, Shi X, Tang D, Zheng Z, He B, Duan T, Gu F, Cheng H, Huang X, Huang Y, Wang R (2010), inventors, Guangzhou Consun Medicine R&D Co., assignee. Pharmaceutical composition for preventing and treating diabetic nephropathy and preparation method thereof. Patent WO2010081264 A. 2010 Jul 22.